John Santilli quoted in Modern Medicine: Ebola clinical activity heats up with vaccine candidates in works

Ebola is unlikely to become a profitable endeavor for Western pharmaceutical companies, “affecting primarily the poor in Africa with demand for drugs relatively modest,” according to John Santilli, of Access Market Intelligence, which provides market intelligence to the pharmaceutical and healthcare industries.

http://formularyjournal.modernmedicine.com/formulary-journal/news/ebola-clinical-activity-speeds-vaccine-candidates-works